Polyprenols: immunomodulatory class-use patent — RU2137479C1
В.И. Рощин · 1999 · RU2137479C1 · patent family 20196666
Published 1999-09-20.
Reported patent results
Narrative findings; numerical extraction incomplete
The direction of immune effects depended on genotype, exposure and assay; the patent does not support a uniformly stimulatory class effect.
Conifer-derived polyprenol immune-response experiments in animals, including stress-associated immune suppression.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Context-dependent immune response | Stimulation occurred under some conditions and suppression under others | No single pooled clinical immune-effect size established |
| Stress-associated findings | Prevention of the reported humoral and macrophage-function impairment described | Animal model; not a patient autoimmune outcome |
These class-level animal findings cannot authenticate or establish efficacy of every Ropren/POLYNCOR formulation, and immune stimulation is not automatically beneficial in autoimmune disease.
Source for the extracted data ↗ · Checked 2026-11-06
Patent claims and provenance
Use. The disclosure concerns polyprenols as an immunomodulatory class.
A chemical-class patent does not authenticate every Ropren or POLYNCOR product, nor demonstrate each product's clinical effect.
- Publication
- RU2137479C1 ↗ · 1999-09-20
- Earliest priority / filing
- 1997-08-27 / 1997-08-27
- Original applicant / assignee
- Солагран Лимитед
- Indexed status
- Not shown; official status unverified · checked 2026-11-06
- Patent family
- 20196666 · family publications are related filings, not independent studies.
Original title, inventors and related publications
Immunomodulating agent
Inventors: В.И. Рощин.
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- A chemical-class patent does not authenticate every Ropren or POLYNCOR product, nor demonstrate each product's clinical effect.
- These class-level animal findings cannot authenticate or establish efficacy of every Ropren/POLYNCOR formulation, and immune stimulation is not automatically beneficial in autoimmune disease.
- Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
- Status labels are Google Patents index snapshots for the displayed publication or application; the record gives its source-check date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original patent text and indexed metadata
Review depth: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.
Related-report group: patent-family-20196666. Reports in this group are not assumed to be independent trials.
Source access and review scope
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Recorded source-check date: 2026-11-06. This date does not imply a completed systematic review.
Source type: Patent publication
Citation and original source
Original source: В.И. Рощин. Polyprenols: immunomodulatory class-use patent — RU2137479C1 RU2137479C1 · patent family 20196666 1999.
Molekul research summary: https://molekul.io/research/patent-ru2137479c1. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry